| Registry | NCT07613892 |
|---|---|
| Status | Completed |
| Phase | Not applicable |
| Study type | Interventional; randomized, single group, masking: none, treatment |
| Enrollment | 60 (Actual) |
| Sponsor | Medline Industries (Industry) |
| Conditions | Wound Closure, Dehisced Surgical Wounds |
| Interventions | Evaluating wound closure products to close larger surgical site incisions, Evaluating wound closure products to close smaller surgical site incisions (Device) |
| Dates | start 2025-04-02, primary completion 2026-03-18, completion 2026-03-18, first posted 2026-05-29, last updated 2026-05-29 |
| Locations | 1 site in United States |
Related Papers Related Patents Related Grants Related Experts
All trials for Wound Closure All trials for Dehisced Surgical Wounds All trials of Evaluating wound closure products to close larger surgical site incisions All trials of Evaluating wound closure products to close smaller surgical site incisions
surgical adhesive systems are used to close surgical cuts and simple skin wounds. This system is a non-invasive option, meaning it can be used instead of stitches or staples. Because these products do not require stitching deep into the skin, they can reduce the time it takes to close a wound and may reduce stress or damage to the skin edges.
The OptiClose surgical adhesive system combines a liquid adhesive with a self-adhering mesh for the closure of surgical incisions and simple lacerations. It acts as a demonstrated noninvasive alternative to skin sutures and staples.
The OptiClose and Dermabond topical skin adhesives combine a self-adhering, pressure sensitive adhesive (PSA), polyester-based mesh (for incisions requiring a mesh), as well as a simple non mesh application system (for incisions that do not require a mesh) for temporarily adjoining the approximated skin edges of an incision, and a 2-octyl cyanoacrylate liquid adhesive formulation for final skin closure. By sparing long intracutaneous sutures, wound closure time is significantly reduced and wound edge ischemia potentially diminished. The purpose of this study is to conduct a two arm, prospective, randomized control trial by which participants will be randomly assigned to either receive the Dermabond wound closure adhesive or the OptiClose wound closure adhesive in participants undergoing the closure of any subcutaneous tissue following surgical site incisions.
| Arm | Type | Interventions | Description |
|---|---|---|---|
| larger incisions requiring mesh are randomized to two a Medline product and the other a comparator | Experimental | Device: Evaluating wound closure products to close larger surgical site incisions | In the first arm, larger incisions (greater than 20cm) requiring mesh are randomized to either OptiClose Secure or Dermabond Prineo. Participants are assessed at three post procedure time points: immediately after skin closure and at two subsequent follow up visits. Study endpoints include cosmetic outcome (cosmesis score), incidence of wound dehiscence or allergic reactions, dry time, and ease of application. Participants complete the study following the final assessment visit, though withdrawal is permitted at any time, and investigators may discontinue participation if clinical concerns arise. The study involved an overall duration of approximately 4-6 months\[SR1\] \[NS2\] , with participant follow up lasting about 4-6 weeks, including a 2 week post operative visit, placing all follow up activities within the referenced 8-12 week completion window.\[ |
| smaller incisions not requiring mesh are closed using adhesive only with participants randomized | Experimental | Device: Evaluating wound closure products to close smaller surgical site incisions | In the second arm, smaller incisions (19 cm or smaller) not requiring mesh are closed using cyanoacrylate-based adhesive ("glue") only, with participants randomized to OptiClose Rapid or Dermabond Advanced. Participants are assessed at three post procedure time points: immediately after skin closure and at two subsequent follow up visits. Study endpoints include cosmetic outcome (cosmesis score), incidence of wound dehiscence or allergic reactions, dry time, and ease of application. Participants complete the study following the final assessment visit, though withdrawal is permitted at any time, and investigators may discontinue participation if clinical concerns arise. The study involved an overall duration of approximately 4-6 months. , with participant follow up lasting about 4-6 weeks, including a 2 week post operative visit, placing all follow up activities within the referenced 8-12 week completion window |
Sex: All, ages: 18 Years to any
Inclusion Criteria: * Are able to understand and willing to carry out instructions for this study. * Full thickness surgical incision requiring subcutaneous closure. Exclusion Criteria: * Known sensitivities/allergies to the ingredients contained in the products. Individuals with a self-reported Type IV hypersensitivity reaction to cyanoacrylates (namely acrylates).
| Facility | City | Country | Status |
|---|---|---|---|
| Nadora Healthcare | Johnstown, Colorado | United States |